Many research labs around the world have temporarily closed their doors in response to the COVID-19 pandemic, while others are experiencing unprecedented need for reagents to perform viral testing. This urgency has led many scientists to make new connections and build creative, collaborative solutions.
“In labs that are still open for testing or other purposes, there’s certainly heightened anxiety,” says Tony Vanden Bush, Client Support Specialist. “I feel that right now, I need to help them deal with that stress however possible.”
Last week, Tony was contacted by a lab at the University of Minnesota that was preparing to serve as a secondary COVID-19 testing facility for a nearby hospital lab. The two labs needed to process up to 6,000 samples per day, and the university lab was far short of that capacity.
As scientists, we often find ourselves fielding questions about events in the news that may or may not be related to our area of expertise. Especially during the ongoing pandemic, it can often be difficult to share accurate information without either sparking panic or understating the severity. Nonetheless, we want to support our friends and family in times of uncertainty, and one way to do that is by sharing accurate information about scientific topics.
We’ve gathered answers to a few frequently asked questions
about the COVID-19 pandemic that we’ve received from family members. Have
question we missed? Submit it in the comments and we’ll get back to you.
Travel and event restrictions related to the COVID-19 pandemic have caused many scientific conferences to be canceled, delayed or adapted into virtual events. These conferences include the Society of Toxicology (SOT), American Association of Cancer Researchers (AACR), Experimental Biology (EB) and the BioPharmaceutical Emerging Best Practices Association (BEBPA) Bioassay Conference, among many others. For the most up-to-date information, we recommend checking with the hosts of each conference.
These cancellations have disrupted many scientists’ plans to present research, engage with potential collaborators and interact with vendors. At Promega, we’re sensitive to the lost opportunities and are currently exploring potential ways to create these experiences despite so many conferences being canceled.
“We want people to be able to talk directly with us and have
the same warm feeling as a close conversation at a conference, but without
being face to face,” says Allison Suchon, Promega Tradeshow Manager. “We’re
looking at different options to have that same conference feeling but without
the show going on around us.”
To make the most of our time while we build solutions, we
asked Promega scientists for tips on staying connected and informed when you
can’t go to conferences. Here are some ideas we gathered.
The 2019 Novel Coronavirus (SARS-CoV-2) is a new virus that emerged in China in late 2019 and quickly jumped into scientific and mainstream news. When facing a potential pandemic, it can be difficult to share information without inducing panic. There’s no doubt that SARS-CoV-2 presents a significant threat to public health, but as with all viruses in their emerging stages, we often find ourselves with more questions than answers. However, through the work of the World Health Organization (WHO), government officials and hardworking scientists worldwide, we can begin to understand some of the details about SARS-CoV-2.
On February 13, 2020, a group of post-docs from the University of Wisconsin – Madison had the opportunity to spend a day at the Promega headquarters in Fitchburg, WI. Throughout the day, the group heard from a list of speakers including Tom Livelli, VP of Life Sciences, and representatives from Technical Services, Sales, R&D and Marketing. The day concluded with a tour of the Feynman Manufacturing Center, where attendees saw production and packing lines, as well as training and QC labs.
On February 13, 2020, a group of post-docs from the
University of Wisconsin – Madison had the opportunity to spend a day at the
Promega headquarters in Fitchburg, WI. Throughout the day, the group heard from
a list of speakers including Tom Livelli, VP of Life Sciences, and
representatives from Technical Services, Sales, R&D and Marketing. The day
concluded with a tour of the Feynman Manufacturing Center, where attendees saw
production and packing lines, as well as training and QC labs.
“It’s always encouraging as a scientist to hear about how
each person is different and how they’ve had different twists and turns,” says Alexa
Heaton, a post-doc studying immunotherapy interactions in mice. “It’s great to
hear from such a range of people and the different job types I could consider.”
To recap the day, we’ve captured a few of the biggest
Later this year, Promega will open a new R&D building with more than twice the current amount of lab space available on the Madison campus. While preparing to move to the new building, R&D scientists are cleaning out decades of scientific history housed in some of the older labs. Meagan Eggers, Promega Strategic Information Partner, is collaborating with the research groups to document and preserve noteworthy artifacts unearthed in the Research & Development Center. Over the next few months, we’ll showcase some of the most interesting things we find.
Spectrometer – 1960s-2000
Promega research scientists began investigating bioluminescent proteins in the early 1990s. One of the most important tools in this research was the spectrometer pictured above, which was used to measure the emission spectra of many different organisms. Before it arrived at Promega, however, this spectrometer began in the space program.
In times of rapid growth, we look to the future with excitement while also assuring that our expansion is sustainable. The Promega Global Facilities Planning Team emphasizes environmental stewardship and long-term planning. Each building is designed to meet ambitious sustainability goals, and innovations incorporated into each project inform the next. In 2019, we finished construction on two new buildings in Europe and made progress on two important facilities at our headquarters in Wisconsin.
Have you read last week’s breaking story about the microbiome of the human placenta? Wait, stop, don’t run away to Google it! I’ll tell you all about it – this is a science blog, remember?
I’m asking because as I started reading about the topic in preparation for writing this blog post, I noticed two things. First, as a science writer who tries to stay well-connected with what’s going on in the world of biology research, it would have been nearly impossible for me to avoid this story. I get eight or nine daily digest emails from scientific publications every day, and I think over the course of last week, every single one came with a headline related to the placenta study. (Of course, I read them all. And the Nature study they were based on.)
Second, I noticed that each story I read had a slightly different angle on covering the research. As scientists, we like to believe that science is, well, just science. It’s factual. We pore over the data and reach a conclusion. If we aren’t sure of something, we search the journals. The story, if there is one, is about methods and controls, protocols and reagent quality. However, when information about that research is communicated broadly, outside of the journals, we can get a different impression based on how the author frames their article. Continue reading ““The Human Placenta,” or “Why I Love Science Writing””
On May 13, 2019, twenty-five meters below the streets of Stockholm in a retired nuclear reactor, Nerea Capon and her iGEM team unveiled an artistic fusion of creativity and synthetic biology. The Synthetic Biology Art Exhibition featured works by other iGEM teams and local artists, all presenting their unique reflections on the concepts of synthetic biology. The collection included synthetic skin grown by bacteria, performance art, and even a musical snail that spent the week crawling around a table full of plants.
It’s FINALLY time to announce the winners of the 2019 Promega iGEM Grant! We received over 150 applications this year, so picking the top 10 was very tough. As always, we’re impressed by the amazing work iGEM teams are doing in the lab and in their communities. The 10 winners listed below will receive $2,000 in free Promega products.